University of Miami Health System, Miller School of Medicine

University of Miami Researchers Report COVID-19 Found in Penile Tissue Could Contribute to ED

First to demonstrate COVID-19 can be present in penile tissue long after recovery

Newswise — University of Miami Miller School of Medicine researchers are the first to demonstrate that COVID-19 can be present in the penis tissue long after men recover from the virus.

The widespread blood vessel dysfunction, or endothelial dysfunction, that results from the COVID-19 infection could then contribute to erectile dysfunction, or ED, according to the study recently published in the World Journal of Men’s Health. Endothelial dysfunction is a condition in which the lining of the small blood vessels fails to perform all of its functions normally. As a result, the tissues supplied by those vessels could undergo damage.

 “Our research shows that COVID-19 can cause widespread endothelial dysfunction in organ systems beyond the lungs and kidneys. The underlying endothelial dysfunction that happens because of COVID-19 can enter the endothelial cells and affect many organs, including the penis,” said study author Ranjith Ramasamy, M.D., associate professor and director of the Miller School’s Reproductive Urology Program. “In our pilot study, we found that men who previously did not complain of erectile dysfunction developed pretty severe erectile dysfunction after the onset of COVID-19 infection.”

 Dr. Ramasamy and colleagues collected penile tissue from two men with a history of COVID-19 infection who underwent penile prosthesis surgery for ED. One of the men was hospitalized for COVID-19, while the other patient only had mild symptoms when he contracted the virus.

 The researchers also collected tissue from two additional men with no history of COVID-19 infection undergoing the same surgery for ED. The investigators analyzed all the tissue samples for not only evidence of the virus but also endothelial dysfunction.

 They found COVID-19 was present in the penile tissue of both men who had been infected, but not in the men with no history of the virus. The men had been infected six and eight months prior, respectively. These men had evidence of endothelial dysfunction, while the men who had been free of the virus did not.

 “This suggests that men who develop COVID-19 infection should be aware that erectile dysfunction could be an adverse effect of the virus, and they should go to a physician if they develop ED symptoms,” Dr. Ramasamy said.

 The authors hypothesize that similar to other COVID-19 related complications, widespread infection and subsequent endothelial dysfunction could result in ED, and that worsening of ED could be due to the virus’s presence in the penile tissue, itself.

 In a previously published study, Dr. Ramasamy and Miller School colleagues found that COVID-19 can also invade testis tissue in some men who are infected with the virus, which might be the first step in understanding the virus’s potential impact on male fertility and whether COVID-19 can be sexually transmitted.

 “These latest findings are yet another reason that we should all do our best to avoid COVID-19,” said first author Eliyahu Kresch, a medical student working with Dr. Ramasamy.

“We recommend vaccination and to try to stay safe in general,” Kresch said.

Miller School coauthors are medical student Justin K. Achua, M.S.; clinical research coordinator Russell Saltzman; clinical research associate Kajal Khodamoradi, Ph.D.; Research Assistant Professor of Urology Himanshu Arora, Ph.D.; Assistant Professor of Urology and Neurological Surgery Emad Ibrahim, M.D., HCLD; Associate Professor of Pathology Oleksandr N. Kryvenko, M.D.; Transmission Electron Microscopy Core Vania Wolff Almeida; Fakiha Firdaus; and Founding Director of the Interdisciplinary Stem Cell Institute Joshua M. Hare, M.D.

SEE ORIGINAL STUDY

MEDIA CONTACT
Register for reporter access to contact details
CITATIONS

World Journal of Men’s Health



Filters close

Showing results

110 of 6084
Newswise: Public
Released: 28-Jul-2021 2:45 PM EDT
Highly Potent, Stable Nanobodies Stop SARS-CoV-2
Max Planck Society (Max-Planck-Gesellschaft)

Göttingen researchers have developed mini-antibodies that efficiently block the coronavirus SARS-CoV-2 and its dangerous new variants.

Newswise: Public
Released: 28-Jul-2021 2:20 PM EDT
Psychological Consequences of COVID-19 in Health Care
University of Bonn

Physicians, nursing staff, medical technical assistants, and pastoral workers in hospitals: they have all been placed under severe strain by the Covid-19 pandemic.

Newswise: Public
Released: 28-Jul-2021 2:10 PM EDT
Why Lockdown in Africa Does Not Work as a First COVID-19 Pandemic Response
University of Johannesburg

In an African pandemic it is more productive to consider lockdowns, after using other non-medical measures first, Especially in countries with high levels of poverty and corruption, says Prof Nicholas Ngepah, a Professor of Economics at the University of Johannesburg in South Africa.

Newswise:Video Embedded how-to-talk-with-people-who-are-not-vaccinated-against-covid-19
VIDEO
Released: 28-Jul-2021 1:40 PM EDT
How to Talk With People Who Are Not Vaccinated Against COVID-19
Cedars-Sinai

Even though she has asthma, putting her at higher risk for severe complications from COVID-19, Angela Reeves-Flores, 33, waited until a week ago to get vaccinated.

Newswise: Indian Women’s Nutrition Suffered During COVID-19 Lockdown
Released: 28-Jul-2021 12:50 PM EDT
Indian Women’s Nutrition Suffered During COVID-19 Lockdown
Cornell University

A new study from Cornell University finds the nationwide lockdown India imposed last year in response to COVID-19 caused disruptions that negatively impacted women’s nutrition.

Released: 28-Jul-2021 12:00 PM EDT
MD Anderson Research Highlights for July 28, 2021
University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include a newly discovered protein that controls B cell survival, understanding epigenetic changes in malignant peripheral nerve sheath tumors (MPNSTs) and melanoma, identifying a protein that protect genome stability, developing novel cell therapies for COVID-19, a new option for treating neuropathic pain, exosome delivery of CRISPR/Cas9 to pancreatic cancer, discovering how cancer cells tolerate aneuploidy and the role of health disparities in long-term survival of adolescent and young adult patients with Hodgkin lymphoma.

Released: 28-Jul-2021 11:30 AM EDT
Study Reveals Characteristics of SARS-CoV-2 Spike Protein
University of Kentucky

A new University of Kentucky College of Medicine study published in the Journal of Biological Chemistry provides foundational information about SARS-CoV-2’s spike protein.

access_time Embargo lifts in 2 days
Embargo will expire: 4-Aug-2021 9:00 AM EDT Released to reporters: 28-Jul-2021 11:15 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Aug-2021 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: UIC Awarded $6 Million to Develop Potential COVID-19 Treatment
Released: 28-Jul-2021 10:15 AM EDT
UIC Awarded $6 Million to Develop Potential COVID-19 Treatment
University of Illinois Chicago

Researchers at the University of Illinois Chicago are developing a potential treatment for COVID-19, thanks to a $6 million technology and therapeutic development award from the U.S. Department of Defense supporting pre-clinical animal studies.

Newswise: Don’t Let the Raging Virus Put Life in Jeopardy. Chula Recommends How to Build an Immunity for Your Heart Against Stress and Depression
Released: 28-Jul-2021 8:55 AM EDT
Don’t Let the Raging Virus Put Life in Jeopardy. Chula Recommends How to Build an Immunity for Your Heart Against Stress and Depression
Chulalongkorn University

Cumulative stress, denial, and chronic depression are the byproducts of the COVID-19 pandemic. The Center for Psychological Wellness, Chulalongkorn University recommends ways to cope by harnessing positive energy from our heart.


Showing results

110 of 6084

close
1.96897